A randomized phase III trial of concurrent chemoradiotherapy in locally advanced cervical cancer: Preliminary results

Gynecologic Oncology

Volumn 104, Issue 1, 2007, Pages 15-23

  Veerasarn, Vutisiri ^a   Lorvidhaya, Vicharn ^b   Kamnerdsupaphon, Pimkhuan ^b   Suntornpong, Nan ^a   Sangruchi, Supatra ^a   Lertsanguansinchai, Prasert ^b   Khorprasert, Chonlakiet ^b   Sookpreedee, Lak ^c   Udompunturak, Suthipol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c Chonburi Cancer Center   (Thailand)

Author keywords

Carboplatin; Cervical cancer; Chemoradiotherapy

Indexed keywords

CARBOPLATIN; HEMOGLOBIN; UFT;

ADVANCED CANCER; ALLERGY; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DIARRHEA; DYSURIA; FATIGUE; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MYALGIA; NAUSEA; NEUTROPENIA; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN TOXICITY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY FREQUENCY; URINE INCONTINENCE; UTERINE CERVIX CANCER; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; TEGAFUR; URACIL; UTERINE CERVICAL NEOPLASMS;

EID: 33846181020     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.06.045     Document Type: Article

References (41)

1. Sriplung H., Sontipong S., Martin N., et al. Cancer Research Foundation for National Cancer Institute. Cancer in Thailand vol. III (1995-1997) 49
2. Lowrey G.C., Mendenhall W.M., and Million R.R. Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: a multivariate analysis. Int. J. Radiat. Oncol. Biol. Phys. 24 2 (1992) 205-210
3. Perez C.A., Grigsby P.W., Nene S.M., et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69 11 (1992) 2796-2806
4. Horiot J.C., Pigneux J., Pourquier H., et al. Radiotherapy alone in carcinoma of the intact uterine cervix according to G. H. Fletcher guidelines: a French cooperative study of 1383 cases. Int. J. Radiat. Oncol. Biol. Phys. 14 4 (1988) 605-611
5. Lanciano R.M., Won M., Coia L., and Hanks G.E. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of he 1973 and 1978 patterns of care studies. Int. J. Radiat. Oncol. Biol. Phys. 20 4 (1991) 667-676
6. International Federation of Gynecology and Obstetrics. In: Pettersson F. (Ed). Annual report on the results of treatment in gynecological cancer (1994), Radium Hemmet, Stockholm
7. John M., Cooke K., Flam M., Padmanabhan A., and Mowry P.A. Preliminary results of concomitant radiotherapy and chemotherapy in advanced cervical carcinoma. Gynecol. Oncol. 28 1 (1987) 101-110
8. Hreschyshyn M.M., Aron B.S., Boronow R.C., et al. Hydroxyureaor placebo combined with radiation to treat stages III B and IV cervical cancer confined to the pelvis. Int. J. Radiat. Oncol. Biol. Phys. 5 3 (1979) 317-322
9. Piver M.S., Khalil M., and Emrich L.J. Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically staged stage III B cervical cancer. J. Surg. Oncol. 42 2 (1989) 120
10. Thomas G., Dembo A., Fyles A., et al. Concurrent chemoradiation in advanced cervical cancer. Gynecol. Oncol. 38 3 (1990) 446-451
11. Kuske R., Perez C., Grigsby P., et al. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced and recurrent gynecological malignancies: a preliminary report. Am. J. Clin. Oncol. 12 6 (1989) 467-473
12. Runowicz C.D., Wadler S., Rodrigurez-Rodriquez L., et al. Concomitant cisplatin and radiotherapy in locally advanced cervical carcinoma. Gynecol. Oncol. 34 3 (1989) 395-401
13. Thomas G., Dembo A., Beale F., et al. Concurrent radiation, mitomycin-C and 5-fluorouracil in poor prognosis carcinoma of cervix. Preliminary result of phase I, II study. In. J. Radiat. Oncol. Biol. Phys. 10 9 (1984) 1785-1790
14. Evan L.S., Kersh C.R., Constable W.C., and Taylor P.T. Concomitant 5-fluorouracil, mitomycin-C and radiotherapy for advanced gynecological malignancies. Int. J. Radiat. Oncol. Biol. Phys. 15 4 (1988) 901-906
15. Drescher C.W., Reid G.C., Terada K., et al. Continuous infusion of low dose 5-fluorouracil and radiation therapy for poor prognosis squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 44 3 (1992) 227-230
16. Malviya V.K., Deppe G., Kim Y., and Gove N. Concurrent radiation therapy, Cis-platinum and mitomycin-C in patients with poor prognosis cancer of the cervix. A pilot study. Am. J. Clin. Oncol. 12 5 (1989) 434-437
17. Whitney C.W., Sause W., Bundy B.N., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 5 (1999) 1339-1348
18. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer. N. Engl. J. Med. 340 15 (1999) 1137-1143
19. Rotman M., Pajak M., Choi K., et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas: ten-year treatment results of RTOG 79-20. JAMA 274 5 (1995) 387-393
20. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer. N. Engl. J. Med. 340 15 (1999) 1144-1153
21. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340 15 (1999) 1154-1161
22. Peters W.A.I., Liu P.Y., Barrett R., et al. Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: report of a phase III Intergroup study. Gynecol. Oncol. 72 3 (1999) 443
23. Muggia F.M. Overview of carboplatin: replacing complementing and extending the therapeutic horizons of cisplatin. Semin. Oncol. 16 Suppl. 5 (1989) 7-13
24. Schwachofer J.H., Crooijmans R.P., and Hoogenhout J. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int. J. Radiat. Oncol. Biol. Phys. 20 6 (1991) 1235-1241
25. Pekkola-Heino K., Kulmala J., and Grenman R. Carboplatin radiation interaction in squamous cell carcinoma cell lines. Arch. Otolaryngol. Head Neck Surg. 118 12 (1992) 1312-1315
26. Yang L.X., Douple E.B., and Wang H.J. Irradiation enhances cellular uptake of carboplatin. Int. J. Radiat. Oncol. Biol. Phys. 33 3 (1995) 641-646
27. McGuire W.P., Arseneau J., Blessing J.A., et al. A randomized comparative trial of carboplatin and iproplatin in advanced squamous carcinoma of the uterine cervix: Gynecologic Oncology Group study. J. Clin. Oncol. 7 10 (1989) 1462-1468
28. Lira-Puerto V., Silva A., Morris M., et al. Phase II trial of carboplatin or iproplatin in cervical cancer. Cancer Chemother. Pharmacol. 28 5 (1991) 391-396
29. Weiss G.R., Green S., Hannigan E.V., et al. A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study. Gynecol. Oncol. 39 3 (1990) 332-336
30. Muggia F.M., and Muderspach L. Platinum compounds in cervical and endometrial cancers: focus on carboplatin. Semin. Oncol. 2 Suppl. 2 (1994) 35-41
31. Lokich J., Bothe A., Fine N., and Perri J. Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 48 12 (1981) 2565-2568
32. Kish J., Ensley J., Jacobs J., Weaver A., Cummings G., and Al-Sarraf M. A randomized trial of cisplatin (CACP + 5-fluorouracil infusion and CACP + 5-FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 56 12 (1985) 2740-2744
33. Byfield JE, Calabro-Jones P, Klisak I, Kulhanian F. Pharmacologic requirements for obtaining sensitization of human tumour cells in vitro to combined 5-fluorouracil or ftorafur and X-rays. Int J Radiot Oncol Biol Phys 1982;8(11):1923-33.
34. Grogan M., Thomas G.M., Melamed I., et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86 8 (1999) 1528-1536
35. Lavey RS, Liu PY, Greer BE, et al. Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group Study. Gynecol Oncol 2004;95(1):145-51.
36. Corn B.W., Hernandez E., Anderson L., Fein D.A., Dunton C.J., and Heller P. Phase I/II study of concomitant irradiation and carboplatin for locally advanced carcinoma of uterine cervix: an interim report. Am. J. Clin. Oncol. 19 3 (1996) 317-321
37. Duenas-Gonzales A., Cetina L., Sauchez B., et al. A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 56 5 (2003) 1361-1365
38. Higgins R.V., Naumann W.R., Hall J.B., and Haake M. Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer. Gynecol. Oncol. 89 3 (2003) 499-503
39. Muderspach L.I., Curtin J.P., Roman L.D., et al. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol. Oncol. 65 2 (1997) 336-342
40. Micheletti E., La Face B., Bianchi E., et al. Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC): a phase I/II and pharmacokinetic study. Am. J. Clin. Oncol. 20 6 (1997) 613-620
41. Dubay R., Rose P.G., O'Malley D.M., Shalodi A.D., Ludin A., and Selim M.A. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer. Gynecol. Oncol. 94 1 (2004) 121-124